Johnson & Johnson has submitted an application to the European Medicines Agency (EMA) seeking approval of nipocalimab to…
Andrea Lobo
Science Writer
Andrea Lobo is a Science writer at Bionews since 2022. She holds a PhD in Cell Biology/Neurosciences, where she studied the molecular pathways that contribute to neurodegeneration/neuroprotection in stroke biology. Between 2011 and 2021, she worked as a postdoctoral and senior researcher at the Institute for Research and Innovation in Health in Porto, focused on the molecular mechanisms involved in drug addiction, particularly neuronal plasticity and remodeling induced by amphetamines. As a research scientist for 19 years, Andrea also participated in academic projects in other research fields, including gene regulation, cancer, and rare diseases. During her professional journey, Andrea also developed her science writing skills by writing/editing scientific papers and grant proposals.
Education
- PhD, Cell Biology/Neuroscience, University of Coimbra, Portugal, 2011
- BSc Biology, University of Coimbra, Portugal, 2002
Professional Organizations and Affiliations
- Member of the Portuguese Society of Medical Writers
Published Works
- Amado, B.; Melo, L.; Pinto, R.; Lobo, A.; Barros, P.; Gomes, J. R. “Ischemic Stroke, Lessons from the Past towards Effective Preclinical Models”. Biomedicines, 2022. DOI: 10.3390/biomedicines10102561.
- Pinto, R.; Matula, J.; Gomez-Lazaro, M.; Sousa, M.; Lobo, A.; Zikmund, T.; Kaiser, J.; Gomes, J.R. “High-resolution micro-CT for 3D infarct characterization and segmentation in mice stroke models.” Scientific Reports 2022. DOI: 10.1038/s41598-022-21494-9.
- Pinto, R.; Magalhães, A., Sousa, M.; Melo, L.; Lobo, A.; Barros, P.; Gomes, J.R. "Bridging the transient intraluminal stroke preclinical model to clinical practice: from improved surgical procedures to a workflow of functional tests." Frontiers Neurology 2022. DOI: 10.3389/fneur.2022.846735.
- Bravo, J.; Ribeiro, I.; Terceiro, A. F.; Andrade, E.B.; Portugal, C. C.; Lopes, I. M.; Azevedo, M. M.; Sousa, M.; Lopes, C.; Lobo, A.; Canedo, T.; Relvas, J. B.; Sumavielle, T. "Neuron–Microglia Contact-Dependent Mechanisms Attenuate Methamphetamine-Induced Microglia Reactivity and Enhance Neuronal Plasticity"." Cells 11 3 (2022): 355. DOI: 10.3390/cells11030355.
- Gomes, João R*; Lobo, Andrea*; Nogueira, Renata; Terceiro, Ana F; Costelha, Susete; Lopes, Igor M; Magalhães, Ana; Summavielle, Teresa; Saraiva, Maria J. "Neuronal megalin mediates synaptic plasticity—a novel mechanism underlying intellectual disabilities in megalin gene pathologies"." Brain Communications 2020, DOI: 10.1093/braincomms/fcaa135. (* co-first authors).
- Sousa, N. A.; Oliveira, G.; de Oliveira, A.; Lopes, A.; Iles, B.; Nogueira, K..; Araújo, T.; Souza, L.; Araújo, A.; Ramos-Jesus, J., Plácido, A.; Amaral, C.; Campelo, Y.; Barbosa, E.; Portugal, C.; Socodato, R.; Lobo, A.; et al. "Novel Ocellatin Peptides Mitigate LPS-induced ROS Formation and NF-kB Activation in Microglia and Hippocampal Neurons." Scientific Reports (2020). DOI: 10.1038/s41598-020-59665-1.
- Braz, Sandra Oliveira*; Cruz, Andrea*; Lobo, Andrea* (co-first authors); Bravo, Joana; Moreira-Ribeiro, Joana; Pereira-Castro, Isabel; Freitas, Jaime; et al. "Expression of Rac1 alternative 3' UTRs is a cell-specific mechanism with a function in dendrite outgrowth in cortical neurons." Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms (2017). DOI: 10.1016/j.bbagrm.2017.03.002. (* co-first authors).
- Baptista, Sofia; Bento, Ana Rita; Gonçalves, Joana; Bernardino, Liliana; Summavielle, Teresa; Lobo, Andrea; Fontes-Ribeiro, Carlos; et al. "Neuropeptide Y promotes neurogenesis and protection against methamphetamine-induced toxicity in mouse dentate gyrus-derived neurosphere cultures." Neuropharmacology (2012). DOI: 10.1016/j.neuropharm.2012.02.015.
- Lobo, Andrea C.; Gomes, João R.; Catarino, Tatiana; Mele, Miranda; Fernandez, Pedro; Inácio, Ana R.; Bahr, Ben A.; et al. "Cleavage of the vesicular glutamate transporters under excitotoxic conditions." Neurobiology of Disease (2011). DOI: 10.1016/j.nbd.2011.07.010.
- Gomes, J. R.; Lobo, A. C.; Melo, C. V.; Inacio, A. R.; Takano, J.; Iwata, N.; Saido, T. C.; et al. "Cleavage of the Vesicular GABA Transporter under Excitotoxic Conditions Is Followed by Accumulation of the Truncated Transporter in Nonsynaptic." Journal of Neuroscience (2011). DOI: 10.1523/jneurosci.3541-10.2011.
Professional Accomplishments
- Award of Best Paper 2012 in Molecular and Cellular Neurobiology, for a paper published as second author in the Journal of Neuroscience
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Andrea Lobo
Surgical removal of the thymus, called a thymectomy, may significantly ease the neurological symptoms of patients older than 65…
UCB’s injection therapy Zilbrysq (zilucoplan) has gained approval in Canada for treating adults with generalized myasthenia gravis (gMG)…
Treatment with nipocalimab led to significant reductions in disease severity among people with generalized myasthenia gravis (gMG), as…
Treatment with Keytruda (pembrolizumab), an immune checkpoint inhibitor (ICI) used to treat cancer, may trigger myasthenia gravis (MG), according…
NMD Pharma announced the dosing of the first patient in a Phase 2b clinical trial of NMD670, its investigational…
A greater reduction in disease severity a month after surgery to remove the thymus gland in myasthenia gravis (MG)…
Blood levels of interleukin-41 (IL-41) — a signaling molecule involved in immune responses — are found to be significantly elevated…
The 2024 National Patient Conference by the Myasthenia Gravis Foundation of America (MGFA) brought together more than 400 members…
People with myasthenia gravis (MG) — particularly those with more severe symptoms — are significantly hindered both in their…